Related Experiment Video
Updated: Jan 31, 2026

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR
Published on: March 1, 2019
Noncoding RNA genes in cancer pathogenesis
Yuri Pekarsky1, Carlo M Croce1
1Department of Cancer Biology and Genetics, The Wexner Medical Center, Columbus, OH, USA.
Abstract:
By using chronic lymphocytic leukemia as target for discovery in cancer pathogenesis we discovered that the great majority of CLLs (75-85%) carry a deletion of miR-15a and miR-16-1 at 13q14. We also discovered that miR-15/16 are negative regulators of the BCL2 oncogene. Thus the loss of the two negative regulators causes BCL2 overexpression and leukemia. A corollary of this is that CLL is very sensitive to the anti BCL2 drug venetoclax that can induce complete remission in CLL patients. Since leukemia patients may carry billions of leukemia cells, it is quite likely that some (few) of the leukemic cells are resistant to venetoclax. Thus, since microRNAs have multiple targets, we looked for other proteins that may be overexpressed in CLL because of the low of miR-15/16. We discovered that ROR1 an embryonal antigen expressed on most (∼ 90%) CLL, but not on normal B cell, is also regulated by miR-15/16. Thus CLL cells are also sensitive to monoclonal antibodies against ROR1. Venetoclax and monoclonal antibodies against ROR1 act synergistically in killing CLL cells.
Insights
Researchers found that most chronic lymphocytic leukemia (CLL) cases involve deletions of miR-15a/miR-16-1, leading to BCL2 overexpression and leukemia. This explains CLL sensitivity to venetoclax and ROR1 targeting, offering new therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Chronic lymphocytic leukemia (CLL) pathogenesis involves genetic alterations.
- MicroRNAs (miRNAs) play crucial roles in cancer development.
- Specific miRNA deletions are implicated in leukemia progression.
Purpose of the Study:
- To investigate the role of miR-15a and miR-16-1 in CLL.
- To identify targets of miR-15/16 in leukemia.
- To explore novel therapeutic strategies for CLL.
Main Methods:
- Analysis of genetic deletions in CLL patients.
- Investigating the regulatory relationship between miR-15/16 and BCL2.
- Identifying other protein targets of miR-15/16 in CLL.
- Assessing sensitivity to venetoclax and anti-ROR1 antibodies.
Main Results:
- The majority of CLL cases (75-85%) exhibit deletion of miR-15a and miR-16-1 at 13q14.
- miR-15/16 are negative regulators of the BCL2 oncogene; their loss leads to BCL2 overexpression.
- ROR1, an embryonal antigen, is also regulated by miR-15/16 and overexpressed in ~90% of CLL.
- CLL cells are sensitive to venetoclax and anti-ROR1 antibodies, with synergistic effects observed.
Conclusions:
- Deletion of miR-15a/miR-16-1 is a key event in CLL pathogenesis, causing BCL2 overexpression.
- ROR1 is a novel target of miR-15/16 in CLL, presenting a therapeutic target.
- Combined targeting of BCL2 with venetoclax and ROR1 with monoclonal antibodies shows synergistic efficacy in eliminating CLL cells.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
RNA Splicing
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...

